Growth Hormone Deficiency
📧 Sign up to get email alerts when something new happens for Growth Hormone Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Growth Hormone Deficiency in Adults (GHDA) [Phase 3]
A Phase 3 trial evaluating growth hormone therapy for adults with growth hormone deficiency has completed; the update does not report result…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Liquid Somatropin Formulation in Children With Growth Hormone Deficiency [Phase 4]
Phase 4 trial update noting completion of a liquid somatropin formulation study in children with growth hormone deficiency.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency [Phase 3]
Phase 3 clinical trial assessing acceptance of a new liquid somatropin formulation for growth hormone deficiency in children has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin [Phase 1]
Phase 1 pharmacokinetic study of somatropin in healthy Caucasian and Japanese subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency [Phase 4]
This Phase 4 trial evaluating cardiovascular effects of growth hormone therapy in adults with growth hormone deficiency has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx® [Phase 1]
Phase 1 dose study in healthy males evaluating safety, pharmacokinetics and pharmacodynamics of NNC126-0083 compared with Norditropin Simple…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 [Phase 2]
A Phase 2 clinical trial evaluated the safety, pharmacokinetics, and pharmacodynamics of NNC126-0083 in adults with growth hormone deficienc…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 [Phase 1]
Phase 1 dose study in healthy Japanese male volunteers evaluating safety, pharmacokinetics and pharmacodynamics of NNC126-0083; the study ha…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) [Phase 2]
Phase 2 trial comparing weekly TransCon hGH (ACP-001) to daily growth hormone injections in children with growth hormone deficiency, assessi…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children [Phase 3]
Phase 3 trial of somatropin (Norditropin) in insulin-like growth factor (IGF) deficient children has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency [Phase 3]
Phase 3 trial evaluating the effect of growth hormone on bone mineral density in young adults with childhood-onset growth hormone deficiency…
-
CLINICAL_TRIALS research · 2017-01-12Clinical Trial Update: Diagnosing Adult Growth Hormone Deficiency [NA]
A clinical trial update describes methods for diagnosing adult growth hormone deficiency. The study has completed.
-
CLINICAL_TRIALS research · 2017-01-05Clinical Trial Update: Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD)
A clinical trial update assessing the minimal important difference for the Treatment Related Impact Measure-Adult Growth Hormone Deficiency …
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Terminated trial evaluating growth in participants treated with Somatropin (Nutropin) using the NuSpin device has posted results.
-
CLINICAL_TRIALS research · 2016-11-17Clinical Trial Update: Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™
An observational study of Norditropin NordiFlex with the NordiFlex PenMate for growth hormone deficiency in children has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) [Phase 3]
A long-term Phase 3 trial assessing growth hormone therapy for adults with growth hormone deficiency has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Growth Hormone and Chromosome 18q- and Abnormal Growth [Phase 3]
Phase 3 trial evaluating growth hormone therapy for individuals with Loss of Chromosome 18q and growth hormone deficiency has completed. The…
-
FDA approval · 2016-06-23FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)
FDA approves a supplemental application for Norditropin (somatropin) from Novo Nordisk, indicating changes to labeling and/or indications.
-
FDA approval · 2016-03-17FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of Recombinant Somatroipn in patients with Growth Hormone Deficiency; the s…
-
FDA approval · 2016-02-26FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) from Genentech, Inc., updating/expanding the product’s approv…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of recombinant human growth hormone in adults with growth hormone deficiency has c…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Hormone Treatment in Growth Hormone and Testosterone Deficient Patients [Phase 2]
A Phase 2 trial of a hormone treatment for growth hormone deficiency and testosterone deficiency was terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors
This clinical trial update discusses the use of transitional growth hormone therapy in cancer survivors with growth hormone deficiency and n…
-
FDA approval · 2015-08-06FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)
The FDA approved a supplemental application for ZOMACTON (somatropin) filed by Ferring Pharmaceuticals Inc., authorizing changes to its appr…